PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, Douglass Hanly Moir Pathology, New South Wales, Australia. Electronic address: mwehrhahn@dhm.com.au.\', \'Department of Endocrinology, Sir Charles Gairdner Hospital, Western Australia, Australia.\', \'Department of Microbiology, Douglass Hanly Moir Pathology, New South Wales, Australia; NSW Health Pathology, Department of Microbiology, Royal North Shore Hospital, New South Wales, Australia.\', \'Department of Microbiology, Clinipath Pathology, Western Australia, Australia.\', \'Department of Microbiology, Sullivan Nicolaides Pathology, Queensland, Australia.\', \'NSW Health Pathology, Department of Microbiology, Royal North Shore Hospital, New South Wales, Australia.\', \'NSW Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead, New South Wales, Australia.\', \'Department of Microbiology, Melbourne Pathology, Victoria, Australia.\', \'Department of Microbiology, Douglass Hanly Moir Pathology, New South Wales, Australia.\', \'NSW Health Pathology, Institute of Clinical Pathology and Medical Research, Westmead, New South Wales, Australia; Faculty of Medicine and Health, University of Sydney, New South Wales, Australia.\', \'Department of Microbiology, Clinpath Pathology, South Australia, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1386-6532(21)00064-010.1016/j.jcv.2021.104797
?:hasPublicationType
?:journal
  • Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
is ?:pmid of
?:pmid
?:pmid
  • 33770657
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all